Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6X4G

Crystal structure of ICOS in complex with ICOS-L and an anti ICOS-L VNAR domain

6X4G の概要
エントリーDOI10.2210/pdb6x4g/pdb
分子名称Inducible T-cell costimulator, ICOS ligand, anti ICOS-L VHH domain VNAR, ... (6 entities in total)
機能のキーワードimmune checkpoint, receptors, glycoproteins, immune system, t-cell, b-cell
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数3
化学式量合計57412.44
構造登録者
Rujas, E.,Sicard, T.,Julien, J.P. (登録日: 2020-05-22, 公開日: 2020-10-14, 最終更新日: 2023-10-18)
主引用文献Rujas, E.,Cui, H.,Sicard, T.,Semesi, A.,Julien, J.P.
Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies.
Nat Commun, 11:5066-5066, 2020
Cited by
PubMed Abstract: The inducible co-stimulator (ICOS) is a member of the CD28/B7 superfamily, and delivers a positive co-stimulatory signal to activated T cells upon binding to its ligand (ICOS-L). Dysregulation of this pathway has been implicated in autoimmune diseases and cancer, and is currently under clinical investigation as an immune checkpoint blockade. Here, we describe the molecular interactions of the ICOS/ICOS-L immune complex at 3.3 Å resolution. A central FDPPPF motif and residues within the CC' loop of ICOS are responsible for the specificity of the interaction with ICOS-L, with a distinct receptor binding orientation in comparison to other family members. Furthermore, our structure and binding data reveal that the ICOS N110 N-linked glycan participates in ICOS-L binding. In addition, we report crystal structures of ICOS and ICOS-L in complex with monoclonal antibodies under clinical evaluation in immunotherapy. Strikingly, antibody paratopes closely mimic receptor-ligand binding core interactions, in addition to contacting peripheral residues to confer high binding affinities. Our results uncover key molecular interactions of an immune complex central to human adaptive immunity and have direct implications for the ongoing development of therapeutic interventions targeting immune checkpoint receptors.
PubMed: 33033255
DOI: 10.1038/s41467-020-18828-4
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.5 Å)
構造検証レポート
Validation report summary of 6x4g
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon